Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 310

1.

Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy.

Nair S, Bar N, Xu ML, Dhodapkar M, Mistry PK.

Mol Genet Metab. 2020 Feb 5. pii: S1096-7192(20)30031-7. doi: 10.1016/j.ymgme.2020.01.009. [Epub ahead of print]

PMID:
32044242
2.

Using technology-enabled social prescriptions to disrupt healthcare.

Jungmann S, Mistry P, Conibear T, Gray M, Jani A.

J R Soc Med. 2020 Feb;113(2):59-63. doi: 10.1177/0141076819877541. No abstract available.

PMID:
32031488
3.

Accuracy of chitotriosidase activity and CCL18 concentration in assessing type I Gaucher disease severity. A systematic review with meta-analysis of individual participant data.

Raskovalova T, Deegan PB, Mistry PK, Pavlova E, Yang R, Zimran A, Berger J, Bourgne C, Pereira B, Labarère J, Berger MG.

Haematologica. 2020 Jan 30. pii: haematol.2019.236083. doi: 10.3324/haematol.2019.236083. [Epub ahead of print]

4.

OSTα deficiency: A disorder with cholestasis, liver fibrosis and congenital diarrhea.

Gao E, Cheema H, Waheed N, Mushtaq I, Erden N, Nelson-Williams C, Jain D, Soroka CJ, Boyer JL, Khalil Y, Clayton PT, Mistry PK, Lifton RP, Vilarinho S.

Hepatology. 2019 Dec 21. doi: 10.1002/hep.31087. [Epub ahead of print]

PMID:
31863603
5.

Attitudes towards child life specialists and their utilization within pediatric urology.

Mistry PK, Morganstern BA, Ahmed H, Palmer LS.

Can J Urol. 2019 Dec;26(6):10022-10025.

PMID:
31860418
6.

Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI.

de Groot M, Patel N, Manavaki R, Janiczek RL, Bergstrom M, Östör A, Gerlag D, Roberts A, Graves MJ, Karkera Y, Fernando D, Mistry P, Walker A, Wisniacki N, Fryer TD, Jimenez-Royo P.

EJNMMI Res. 2019 Dec 19;9(1):113. doi: 10.1186/s13550-019-0576-8.

7.

A social prescriptions formulary: bringing social prescribing on par with pharmaceutical prescribing.

Jani A, Pitini E, Jungmann S, Adamo G, Conibear J, Mistry P.

J R Soc Med. 2019 Dec;112(12):498-502. doi: 10.1177/0141076819877555. Review. No abstract available.

PMID:
31825285
8.

The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease.

Drelichman G, Castañeda-Hernández G, Cem Ar M, Dragosky M, Garcia R, Lee H, Moiseev S, Naderi M, Rosenbaum H, Žnidar I, Zuluaga AF, Freisens S, Mistry PK.

Am J Hematol. 2020 Mar;95(3):233-237. doi: 10.1002/ajh.25701. Epub 2019 Dec 23. No abstract available.

9.

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial.

Jones DA, Mistry P, Dalby M, Fulton-Lieuw T, Kong AH, Dunn J, Mehanna HM, Gray AM.

Eur J Cancer. 2020 Jan;124:178-185. doi: 10.1016/j.ejca.2019.10.025. Epub 2019 Nov 30.

10.

Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus.

Mistry P, Nakabo S, O'Neil L, Goel RR, Jiang K, Carmona-Rivera C, Gupta S, Chan DW, Carlucci PM, Wang X, Naz F, Manna Z, Dey A, Mehta NN, Hasni S, Dell'Orso S, Gutierrez-Cruz G, Sun HW, Kaplan MJ.

Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25222-25228. doi: 10.1073/pnas.1908576116. Epub 2019 Nov 21.

PMID:
31754025
11.

Etiology of cirrhosis in the young.

Olave MC, Gurung A, Mistry PK, Kakar S, Yeh M, Xu M, Wu TT, Torbenson M, Jain D.

Hum Pathol. 2019 Nov 5. pii: S0046-8177(19)30194-7. doi: 10.1016/j.humpath.2019.09.015. [Epub ahead of print]

PMID:
31698008
12.

Preparation of Primary Rat Hepatocyte Spheroids Utilizing the Liquid-Overlay Technique.

Kyffin JA, Cox CR, Leedale J, Colley HE, Murdoch C, Mistry P, Webb SD, Sharma P.

Curr Protoc Toxicol. 2019 Sep;81(1):e87. doi: 10.1002/cptx.87.

13.

Artificial intelligence in primary care.

Mistry P.

Br J Gen Pract. 2019 Aug 29;69(686):422-423. doi: 10.3399/bjgp19X705137. Print 2019 Sep. No abstract available.

PMID:
31467001
14.

Reply to: "Whole exome sequencing for personalized hepatology: Expanding applications in adults and challenges".

Hakim A, Mistry PK, Vilarinho S.

J Hepatol. 2019 Oct;71(4):850-851. doi: 10.1016/j.jhep.2019.07.005. Epub 2019 Aug 1. No abstract available.

PMID:
31378425
15.

Gaucher disease in Montenegro - genotype/phenotype correlations: Five cases report.

Vujosevic S, Medenica S, Vujicic V, Dapcevic M, Bakic N, Yang R, Liu J, Mistry PK.

World J Clin Cases. 2019 Jun 26;7(12):1475-1482. doi: 10.12998/wjcc.v7.i12.1475.

16.

Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease.

Afinogenova Y, Ruan J, Yang R, Kleytman N, Pastores G, Lischuk A, Mistry PK.

Mol Genet Metab. 2019 Sep - Oct;128(1-2):62-67. doi: 10.1016/j.ymgme.2019.07.014. Epub 2019 Jul 23.

PMID:
31358474
17.

Lessons from lung transplantation: Cause for redefining the pathophysiology of pulmonary hypertension in gaucher disease.

Goobie GC, Sirrs SM, Yee J, English JC, Bergeron C, Nador R, Swiston JR, Mistry PK, Paquin W, Levy RD.

Respir Med Case Rep. 2019 Jun 29;28:100893. doi: 10.1016/j.rmcr.2019.100893. eCollection 2019.

18.

Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy.

Beshlawy AE, Murugesan V, Mistry PK, Eid K.

Mol Genet Metab Rep. 2019 Jun 28;20:100490. doi: 10.1016/j.ymgmr.2019.100490. eCollection 2019 Sep.

19.

Gaucher Disease in Bone: From Pathophysiology to Practice.

Hughes D, Mikosch P, Belmatoug N, Carubbi F, Cox T, Goker-Alpan O, Kindmark A, Mistry P, Poll L, Weinreb N, Deegan P.

J Bone Miner Res. 2019 Jun;34(6):996-1013. doi: 10.1002/jbmr.3734. Epub 2019 Jun 24. Review.

20.

Exome Sequencing in Clinical Hepatology.

Vilarinho S, Mistry PK.

Hepatology. 2019 Dec;70(6):2185-2192. doi: 10.1002/hep.30826. Review.

PMID:
31222768
21.

Assessing facial recognition after orthognathic surgery at automated border controls in airports.

Keshtgar S, Keshtgar A, Mistry P, Shakib K.

Br J Oral Maxillofac Surg. 2019 Jul;57(6):536-538. doi: 10.1016/j.bjoms.2018.12.021. Epub 2019 May 18.

PMID:
31113651
22.

Mathematical modelling of a liver hollow fibre bioreactor.

Sorrell I, Shipley RJ, Regan S, Gardner I, Storm MP, Ellis M, Ward J, Williams D, Mistry P, Salazar JD, Scott A, Webb S.

J Theor Biol. 2019 Aug 21;475:25-33. doi: 10.1016/j.jtbi.2019.05.008. Epub 2019 May 14.

PMID:
31100294
23.

Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus.

Rahman S, Sagar D, Hanna RN, Lightfoot YL, Mistry P, Smith CK, Manna Z, Hasni S, Siegel RM, Sanjuan MA, Kolbeck R, Kaplan MJ, Casey KA.

Ann Rheum Dis. 2019 Jul;78(7):957-966. doi: 10.1136/annrheumdis-2018-214620. Epub 2019 Apr 30.

24.

Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.

Mistry PK, Balwani M, Baris HN, Turkia HB, Burrow TA, Charrow J, Cox GF, Danda S, Dragosky M, Drelichman G, El-Beshlawy A, Fraga C, Freisens S, Gaemers S, Hadjiev E, Kishnani PS, Lukina E, Maison-Blanche P, Martins AM, Pastores G, Petakov M, Peterschmitt MJ, Rosenbaum H, Rosenbloom B, Underhill LH, Cox TM.

Blood Cells Mol Dis. 2019 Jul;77:101-102. doi: 10.1016/j.bcmd.2019.04.003. Epub 2019 Apr 9. No abstract available.

PMID:
31029022
25.

Clinical utility of genomic analysis in adults with idiopathic liver disease.

Hakim A, Zhang X, DeLisle A, Oral EA, Dykas D, Drzewiecki K, Assis DN, Silveira M, Batisti J, Jain D, Bale A, Mistry PK, Vilarinho S.

J Hepatol. 2019 Jun;70(6):1214-1221. doi: 10.1016/j.jhep.2019.01.036. Epub 2019 Apr 15.

PMID:
31000363
26.

The Safety and Tolerability of a Potential Alginate-Based Iron Chelator; Results of A Healthy Participant Study.

Horniblow RD, Mistry P, Quraishi MN, Beggs AD, Van de Wiele T, Iqbal TH, Tselepis C.

Nutrients. 2019 Mar 21;11(3). pii: E674. doi: 10.3390/nu11030674.

27.

The Expression and Transfer of Valence Associated with Social Conformity.

Mistry P, Liljeholm M.

Sci Rep. 2019 Feb 15;9(1):2154. doi: 10.1038/s41598-019-38560-4.

28.

Characterisation of a functional rat hepatocyte spheroid model.

Kyffin JA, Sharma P, Leedale J, Colley HE, Murdoch C, Harding AL, Mistry P, Webb SD.

Toxicol In Vitro. 2019 Mar;55:160-172. doi: 10.1016/j.tiv.2018.12.014. Epub 2018 Dec 20.

29.

Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.

Liu Y, Lightfoot YL, Seto N, Carmona-Rivera C, Moore E, Goel R, O'Neil L, Mistry P, Hoffmann V, Mondal S, Premnath PN, Gribbons K, Dell'Orso S, Jiang K, Thompson PR, Sun HW, Coonrod SA, Kaplan MJ.

JCI Insight. 2018 Dec 6;3(23). pii: 124729. doi: 10.1172/jci.insight.124729.

30.

Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD).

Wasserstein M, Dionisi-Vici C, Giugliani R, Hwu WL, Lidove O, Lukacs Z, Mengel E, Mistry PK, Schuchman EH, McGovern M.

Mol Genet Metab. 2019 Feb;126(2):98-105. doi: 10.1016/j.ymgme.2018.11.014. Epub 2018 Nov 29. Review.

31.

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.

Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group.

Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15.

32.

Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome.

Mistry P, Carmona-Rivera C, Ombrello AK, Hoffmann P, Seto NL, Jones A, Stone DL, Naz F, Carlucci P, Dell'Orso S, Gutierrez-Cruz G, Sun HW, Kastner DL, Aksentijevich I, Kaplan MJ.

Ann Rheum Dis. 2018 Dec;77(12):1825-1833. doi: 10.1136/annrheumdis-2018-213746. Epub 2018 Aug 21.

33.

Evaluation of patient-reported outcome measurements as a reliable tool to measure acceptability of the taste of paediatric medicines in an inpatient paediatric population.

Mistry P, Stirling H, Callens C, Hodson J, Batchelor H; SPaeDD-UK project.

BMJ Open. 2018 Jul 11;8(7):e021961. doi: 10.1136/bmjopen-2018-021961.

34.

Acceptability of placebo multiparticulate formulations in children and adults.

Lopez FL, Mistry P, Batchelor HK, Bennett J, Coupe A, Ernest TB, Orlu M, Tuleu C.

Sci Rep. 2018 Jun 15;8(1):9210. doi: 10.1038/s41598-018-27446-6.

35.

Building a model for day case hiatal surgery - Lessons learnt over a 10 year period in a high volume unit: A case series.

Mistry P, Zaman S, Shapey I, Daskalakis M, Nijjar R, Richardson M, Super P, Singhal R.

Int J Surg. 2018 Jun;54(Pt A):82-85. doi: 10.1016/j.ijsu.2018.04.039. Epub 2018 Apr 25.

PMID:
29704563
36.

Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.

Mistry PK, Balwani M, Baris HN, Turkia HB, Burrow TA, Charrow J, Cox GF, Danda S, Dragosky M, Drelichman G, El-Beshlawy A, Fraga C, Freisens S, Gaemers S, Hadjiev E, Kishnani PS, Lukina E, Maison-Blanche P, Martins AM, Pastores G, Petakov M, Peterschmitt MJ, Rosenbaum H, Rosenbloom B, Underhill LH, Cox TM.

Blood Cells Mol Dis. 2018 Jul;71:71-74. doi: 10.1016/j.bcmd.2018.04.001. Epub 2018 Apr 9. No abstract available.

37.

Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.

Carlucci PM, Purmalek MM, Dey AK, Temesgen-Oyelakin Y, Sakhardande S, Joshi AA, Lerman JB, Fike A, Davis M, Chung JH, Playford MP, Naqi M, Mistry P, Gutierrez-Cruz G, Dell'Orso S, Naz F, Salahuddin T, Natarajan B, Manna Z, Tsai WL, Gupta S, Grayson P, Teague H, Chen MY, Sun HW, Hasni S, Mehta NN, Kaplan MJ.

JCI Insight. 2018 Apr 19;3(8). pii: 99276. doi: 10.1172/jci.insight.99276. eCollection 2018 Apr 19.

38.

Antigen-mediated regulation in monoclonal gammopathies and myeloma.

Nair S, Sng J, Boddupalli CS, Seckinger A, Chesi M, Fulciniti M, Zhang L, Rauniyar N, Lopez M, Neparidze N, Parker T, Munshi NC, Sexton R, Barlogie B, Orlowski R, Bergsagel L, Hose D, Flavell RA, Mistry PK, Meffre E, Dhodapkar MV.

JCI Insight. 2018 Apr 19;3(8). pii: 98259. doi: 10.1172/jci.insight.98259. eCollection 2018 Apr 19.

39.

MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association.

Weinreb NJ, Mistry PK, Rosenbloom BE, Dhodapkar MV.

Blood. 2018 May 31;131(22):2500-2501. doi: 10.1182/blood-2018-02-834689. Epub 2018 Apr 12. No abstract available.

40.

Analysis of the Variability of Abstract Structures in Medical Journals.

Eid T, vanSonnenberg E, Azar A, Mistry P, Eid K, Kang P.

J Gen Intern Med. 2018 Jul;33(7):1013-1014. doi: 10.1007/s11606-018-4428-4. No abstract available.

41.

Infected retroperitoneal fat necrosis after laparoscopic partial nephrectomy.

Nethala D, Wu WJ, Mistry PK, Richstone L.

Urol Case Rep. 2018 Feb 3;17:103-105. doi: 10.1016/j.eucr.2018.01.016. eCollection 2018 Mar. No abstract available.

42.

Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis.

Mistry P, Currie V, Super P, le Roux CW, Tahrani AA, Singhal R.

Clin Obes. 2018 Jun;8(3):151-158. doi: 10.1111/cob.12244. Epub 2018 Mar 4.

PMID:
29504275
43.

Diagnosis and Management of Gaucher Disease in India - Consensus Guidelines of the Gaucher Disease Task Force of the Society for Indian Academy of Medical Genetics and the Indian Academy of Pediatrics.

Puri RD, Kapoor S, Kishnani PS, Dalal A, Gupta N, Muranjan M, Phadke SR, Sachdeva A, Verma IC, Mistry PK; Gaucher Disease Task Force.

Indian Pediatr. 2018 Feb 15;55(2):143-153.

44.

Hepatocellular carcinoma in Gaucher disease: an international case series.

Regenboog M, van Dussen L, Verheij J, Weinreb NJ, Santosa D, Vom Dahl S, Häussinger D, Müller MN, Canbay A, Rigoldi M, Piperno A, Dinur T, Zimran A, Mistry PK, Salah KY, Belmatoug N, Kuter DJ, Hollak CEM.

J Inherit Metab Dis. 2018 Sep;41(5):819-827. doi: 10.1007/s10545-018-0142-y. Epub 2018 Feb 8.

45.

Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States.

Furie RA, Wallace DJ, Aranow C, Fettiplace J, Wilson B, Mistry P, Roth DA, Gordon D.

Arthritis Rheumatol. 2018 Jun;70(6):868-877. doi: 10.1002/art.40439. Epub 2018 Apr 25.

46.

Impact of cell types and culture methods on the functionality of in vitro liver systems - A review of cell systems for hepatotoxicity assessment.

Kyffin JA, Sharma P, Leedale J, Colley HE, Murdoch C, Mistry P, Webb SD.

Toxicol In Vitro. 2018 Apr;48:262-275. doi: 10.1016/j.tiv.2018.01.023. Epub 2018 Feb 1. Review.

47.

Prediction of surgical complications in the elderly: Can we improve outcomes?

Mistry PK, Gaunay GS, Hoenig DM.

Asian J Urol. 2017 Jan;4(1):44-49. doi: 10.1016/j.ajur.2016.07.001. Epub 2016 Aug 18. Review.

48.

Therapeutic position of eliglustat.

Cox TM, Mistry PK.

Blood Cells Mol Dis. 2018 Mar;69:117-118. doi: 10.1016/j.bcmd.2017.11.001. Epub 2017 Nov 22. No abstract available.

PMID:
29187290
49.

Integrated metabolic models for xenobiotic induced mitochondrial toxicity in skeletal muscle.

Dott W, Wright J, Cain K, Mistry P, Herbert KE.

Redox Biol. 2018 Apr;14:198-210. doi: 10.1016/j.redox.2017.09.006. Epub 2017 Sep 18.

50.

Cardiac Clocks and Preclinical Translation.

Mistry P, Duong A, Kirshenbaum L, Martino TA.

Heart Fail Clin. 2017 Oct;13(4):657-672. doi: 10.1016/j.hfc.2017.05.002. Epub 2017 Jun 26. Review.

Supplemental Content

Loading ...
Support Center